Regulations.gov document
Final Response Letter from FDA CDER to Reyoung Pharmaceutical Co., Ltd.
Other · FDA-2023-P-5675 · posted Feb 23, 2024
Key facts
| Document ID | FDA-2023-P-5675-0006 |
|---|---|
| Title | Final Response Letter from FDA CDER to Reyoung Pharmaceutical Co., Ltd. |
| Document type | Other |
| Subtype | Denial of Petition |
| Agency | FDA |
| Docket | FDA-2023-P-5675 |
| Posted | Feb 23, 2024 |
| Comment period opens | Feb 23, 2024 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: